Literature DB >> 3084747

Lorazepam therapy of status epilepticus in children and adolescents.

D J Lacey, W D Singer, S J Horwitz, H Gilmore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3084747     DOI： 10.1016/s0022-3476(86)81065-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  An approach to respiratory distress and central nervous system emergencies.

Authors:  N Kissoon; D Vidyasagar
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

2.  Challenges in the design and analysis of non-inferiority trials: a case study.

Authors:  Valerie Durkalski; Robert Silbergleit; Daniel Lowenstein
Journal:  Clin Trials       Date:  2011-09-15       Impact factor: 2.486

Review 3.  Management of generalized tonic-clonic status epilepticus.

Authors:  K S Krishnamoorthy
Journal:  Indian J Pediatr       Date:  1994 Jan-Feb       Impact factor: 1.967

4.  Children with seizures presenting to accident and emergency.

Authors:  R A Smith; T Martland; M F Lowry
Journal:  J Accid Emerg Med       Date:  1996-01

Review 5.  Guidelines for stabilizing the condition of the critically ill child before transfer to a tertiary care facility.

Authors:  J B Kronick; N Kissoon; T C Frewen
Journal:  CMAJ       Date:  1988-08-01       Impact factor: 8.262

6.  Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.

Authors:  Simon N Muchohi; Kenneth Obiero; Charles R J C Newton; Bernhards R Ogutu; Geoffrey Edwards; Gilbert O Kokwaro
Journal:  Br J Clin Pharmacol       Date:  2007-07-17       Impact factor: 4.335

Review 7.  Febrile seizures.

Authors:  Sajun Chung
Journal:  Korean J Pediatr       Date:  2014-09-30

Review 8.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.